- Page 2 and 3:
WORLD HEALTH ORGANIZATION INTERNATI
- Page 4 and 5:
Contents Foreword .................
- Page 6 and 7:
Foreword The maintenance of a regis
- Page 8 and 9:
2 Introduction and an increased exp
- Page 10 and 11:
4 G. Wagner the first time to elimi
- Page 12 and 13:
6 G. Wagner International Symposium
- Page 14 and 15:
8 0. M. Jensen and H.H. Storm made
- Page 16 and 17:
k d Table 2. Worldwide variation in
- Page 18 and 19:
O.M. Jensen and H.H. Storm Hodgkin
- Page 20 and 21:
O.M. Jensen and H.H. Storm ~i~ure 2
- Page 22 and 23:
16 O.M. Jensen and H.H. Storm 1oo.0
- Page 24 and 25:
0. M. Jensen and H. H. Storm Figure
- Page 26 and 27:
O.M. Jensen and H.H. Storm -44 year
- Page 28 and 29: Chapter 4. Planning a cancer regist
- Page 30 and 31: 24 0. M. Jensen and S. Whelan parti
- Page 32 and 33: 26 0. M. Jensen and S. Whelan Numbe
- Page 34 and 35: 28 0. M. Jensen and S. Whelan Concl
- Page 36 and 37: 30 J. Powell sources, firstly, to p
- Page 38 and 39: 32 J. Powell reports. If a histolog
- Page 40 and 41: 34 J. Powell needs but conserving t
- Page 42 and 43: 36 J. Powell Health insurance (work
- Page 44 and 45: 38 J. Powell episodes-that is, with
- Page 46 and 47: The disadvantages are : - the quali
- Page 48 and 49: 42 J. Powell (c) medical doctors in
- Page 50 and 51: 44 R. MacLennan Table 1. Basic info
- Page 52 and 53: codes (population groups, occupatio
- Page 54 and 55: 48 R. MacLennan morphology (item 21
- Page 56 and 57: 50 R. MacLennan or convention to th
- Page 58 and 59: facilities and to the acceptance of
- Page 60 and 61: 54 R . MacLennan second generation
- Page 62 and 63: 56 R. MacLennan Item 18 : Certainty
- Page 64 and 65: 2. Carcinoma in situ Intraepithelia
- Page 66 and 67: code allocated as item 20 should re
- Page 68 and 69: Hospital registries will wish to el
- Page 70 and 71: Chapter 7. Classification and codin
- Page 72 and 73: 66 C.S. Muir and C. Percy Primarily
- Page 74 and 75: 68 C.S. Muir and C. Percy obtained
- Page 76 and 77: 70 C.S. Muir and C. Percy Topograph
- Page 80 and 81: 74 C.S. Muir and C. Percy users wis
- Page 82 and 83: 76 C.S. Muir and C. Percy example o
- Page 84 and 85: 78 C.S. Muir and C. Percy the rubri
- Page 86 and 87: 80 C.S. Muir and C. Percy be able t
- Page 88 and 89: Chapter 8. Manual and computerized
- Page 90 and 91: 84 R.G. Skeet Multiple notiJication
- Page 92 and 93: 86 R.G. Skeet Name Sex Date of birt
- Page 94 and 95: 88 R.G. Skeet computer then searche
- Page 96 and 97: 90 R.G. Skeet of analysis or select
- Page 98 and 99: 92 R.G. Skeet The accession registe
- Page 100 and 101: 94 R.G. Skeet changes which are irr
- Page 102 and 103: 96 R.G. Skeet 1 Number Name check A
- Page 104 and 105: 98 R.G. Skeet If the patient died i
- Page 106 and 107: 100 R.G. Skeet wrong, the original
- Page 108 and 109: 102 R.G. Skeet should be absent. Th
- Page 110 and 111: R.G. Skeet In a quality control exe
- Page 112 and 113: 106 R.G. Skeet Table 1. Error and w
- Page 114 and 115: Chapter 10. Reporting of results Oi
- Page 116 and 117: I10 0. M. Jensen and H. H. Storm in
- Page 118 and 119: 112 O.M. Jensen and H.H. Storm (5)
- Page 120 and 121: Table 1. Numbers of new cases of ca
- Page 122 and 123: Table .- 2. - Average - annual age-
- Page 124 and 125: O.M. Jensen and H.H. Storm Table 3.
- Page 126 and 127: 0. M. Jensen and H.H. Storm Respira
- Page 128 and 129:
O.M. Jensen and H.H. Storm Year of
- Page 130 and 131:
O.M. Jensen and H.H. Storm DIgestlv
- Page 132 and 133:
Chapter 11. Statistical methods for
- Page 134 and 135:
128 P. Boyle and D.M. Parkin Table
- Page 136 and 137:
130 P. Boyle and D. M. Parkin
- Page 138 and 139:
132 P. Boyle and D.M. Parkin
- Page 140 and 141:
134 P. Boyle and D.M. Parkin
- Page 142 and 143:
136 P. Boyle and D.M. Parkin
- Page 144 and 145:
138 P. Boyle and D.M. Parkin An alt
- Page 146 and 147:
140 P. Boyle and D. M. Parkin Table
- Page 148 and 149:
142 P. Boyle and D.M. Parkin The ca
- Page 150 and 151:
144 P. Boyle and D.M. Parkin
- Page 152 and 153:
146 P. Boyle and D.M. Parkin Divisi
- Page 154 and 155:
148 P. Boyle and D.M. Parkin It is
- Page 156 and 157:
150 P. Boyle and D. M. Parkin and h
- Page 158 and 159:
P. Boyle and D. M. Parkin Male Fema
- Page 160 and 161:
154 P. Boyle and D.M. Parkin where
- Page 162 and 163:
156 P. Boyle and D.M. Parkin where
- Page 164 and 165:
158 P. Boyle and D.M. Parkin becaus
- Page 166 and 167:
160 D.M. Parkin and T. Hakulinen pu
- Page 168 and 169:
162 D.M. Parkin and T. Hakulinen in
- Page 170 and 171:
164 D.M. Parkin and T. Hakulinen co
- Page 172 and 173:
D.M. Parkin and T. Hakulinen --- Co
- Page 174 and 175:
168 D. M. Parkin and T. Hakulinen r
- Page 176 and 177:
170 D. M. Parkin and T. Hakulinen -
- Page 178 and 179:
172 D.M. Parkin and T. Hakulinen by
- Page 180 and 181:
174 D.M. Parkin and T. Hakulinen (P
- Page 182 and 183:
176 D. M. Parkin and T. Hakulinen s
- Page 184 and 185:
178 J.L. Young patient care evaluat
- Page 186 and 187:
180 J.L. Young - the ambiguous term
- Page 188 and 189:
J.L. Young - First course of treatm
- Page 190 and 191:
184 J.L. Young - a report of regist
- Page 192 and 193:
186 D.M. Parkin and L.D. Sanghvi (M
- Page 194 and 195:
188 D.M. Parkin and L.D. Sanghvi Id
- Page 196 and 197:
190 D.M. Parkin and L.D. Sanghvi ad
- Page 198 and 199:
D.M. Parkin and L.D. Sanghvi treate
- Page 200 and 201:
194 D.M. Parkin and L.D. Sanghui (8
- Page 202 and 203:
196 D.M. Parkin and L.D. Sanghui ta
- Page 204 and 205:
198 D.M. Parkin and L.D. Sanghvi Co
- Page 206 and 207:
200 C.S. Muir and E. Dimare2 the re
- Page 208 and 209:
202 C.S. Muir and E. Dkmaret Mail A
- Page 210 and 211:
204 C.S. Muir and E. Dimaret When c
- Page 212 and 213:
206 C.S. Muir and E. DPmaret If, on
- Page 214 and 215:
Appendix 1. United Nations Standard
- Page 216 and 217:
210 Appendix 1 388 Jamaica 562 Nige
- Page 218 and 219:
Appendix 2. Editing for consistency
- Page 220 and 221:
Appendix 2 Table 1 - continued (Not
- Page 222 and 223:
216 Appendix 2 Table 1 - continued
- Page 224 and 225:
218 Appendix 2 Table 2 - continued
- Page 226 and 227:
Appendix 3 (a) The Danish Cancer Re
- Page 228 and 229:
222 Appendix 3(a) Table 1. Data sou
- Page 230 and 231:
Table 2. Percentage distribution of
- Page 232 and 233:
CPR. nr. Eflernavn Appendix 3(a) An
- Page 234 and 235:
228 Appendix 3(a) Seceret tilfaelde
- Page 236 and 237:
~ I Death certificate tumours (year
- Page 238 and 239:
232 Appendix 3(a) calendar-week. Wh
- Page 240 and 241:
234 Appendix 3(a) -if curative surg
- Page 242 and 243:
236 Appendix 3(a) in the main regis
- Page 244 and 245:
REQISTRATION FORM CRF 1 On cowldon
- Page 246 and 247:
240 Appendix 3(b) Clinical details
- Page 248 and 249:
Appendix 3(b) Ask GP if patient att
- Page 250 and 251:
244 Appendix 3(b) Retrospective che
- Page 252 and 253:
Appendix 3 (c) Cancer registration
- Page 254 and 255:
248 Appendix 3(c) consisting of rec
- Page 256 and 257:
250 Appendix 3(c) identifying varia
- Page 258 and 259:
252 Appendix 3(c) Allocation of sit
- Page 260 and 261:
254 Appendix 3(c) Table 2. Variable
- Page 262 and 263:
256 Appendix 3(c) Another problem w
- Page 264 and 265:
Appendix 3 (d) The Department of He
- Page 266 and 267:
Appendix 3(d) RIZAL MZDICAL CB;\IT!
- Page 268 and 269:
Appendix 3(d) Population-Based Canc
- Page 270 and 271:
264 Appendix 3(d) indicated in red
- Page 272 and 273:
266 Appendix 3(d) married name in a
- Page 274 and 275:
268 Appendix 4 f \ Data Entry Fiji
- Page 276 and 277:
Language compatibility Appendix 4 U
- Page 278 and 279:
Appendix 4 .- Female -. 1986 - 1987
- Page 280 and 281:
274 Appendix 4 Installed user base
- Page 282 and 283:
276 References T. G., Koch, M., Kre
- Page 284 and 285:
278 References Treatment for Cervic
- Page 286 and 287:
280 References Lyon, J. L. & Gardne
- Page 288 and 289:
282 References Peto, R., Pike, M. C
- Page 290 and 291:
284 References Vandenbroucke, J. P.
- Page 292 and 293:
286 Subject Index Data sources auto
- Page 294:
288 Subject Index Security see Conf